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A B S T R A C T
The aim of this randomized, prospective, study was to evaluate postoperative hospital mortality and morbidity after
mitral valve repair by comparing two surgical techniques for resolving mitral valve insufficiency in elderly patients. In
comparison were: mitral valve repair vs. mitral valve replacement in patients older than 70 years. In period from Janu-
ary 1st 2006 until August 30th 2009. Eighty patients with mitral valve disease, isolated or associated with other co mor-
bidities, were scheduled for mitral valve repair or mitral valve replacement in our institution. Patients were randomized
in two groups, one scheduled for mitral valve repair and another one for mitral valve replacement using the envelope
method with random numbers. Results show no difference in hospital mortality and morbidity postoperatively in both
groups. In group undergoing valve replacement we had one significant complication of ventricle rupture in emphatically
calcified posterior part of mitral valve annulus. In conclusion we found no distinction in postoperative hospital mortality
and morbidity after using one of two surgical techniques.
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Introduction
In last decade there is an increasing number of pa-
tients older than 70 years scheduled for cardiac surgery1.
Mitral valve (MV) repair is an established surgical me-
thod for the treatment of mitral insufficiency (MI). MV
repair is more preferred over replacement in younger pa-
tients, but in patients over 70 years it is still contro-
versial2–4. MV surgery in older people requires great
skills and experience because of cardiac and non-cardiac
co morbidities5–7. Older patients often are not scheduled
for MV repair because of co morbidities and perception
that they may not tolerate prolonged cardiopulmonary
bypass in case of inadequate repair. Elderly patients, in
presumption, do not benefit from MV repair due to short
life expectancy. Therefore, the objective of this study is
focused on postoperative hospital mortality and morbid-
ity after MV repair in elderly.
Patients and Methods
After obtaining approval from the Medical Faculty
Ethics Committee and consent from all the patients,
eighty consecutive patients older than 70 years with MV
insufficiency were scheduled to undergo MV repair or re-
placement from January 1st 2007 to June 30th 2009 in our
institution. Patients with previous MV surgical treat-
ment, myocardial infarction within 7 days, and younger
then 70 years were excluded from the study. Both groups
were randomized using the envelope method with random
numbers. Demographic and clinical profiles of groups are
presented in Table 1. There were no significant differ-
ences between two groups in age, sex, weight, height, co
morbidities, and medications. General anesthesia (with
the application of propofol, midazolam, atracuronium,
and inhaled isofluranum) was facilitated. Heparin was
administrated in dosage of 3 mg/kg to achieve an acti-
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vated clotting time (ACT) >480 sec. Protamine was used
to reverse the effect of heparin at the dose ratio of 1.5:1.
Surgical technique
Surgical access was through a full midline sternotomy
on full cardiopulmonary bypass within all cases. Moder-
ate systemic hypothermia was used. Anterograde Cala-
fiore cardioplegia followed with retrograde cardioplegia
was delivered. MV approach was through the right in-
teratrial grove atriotomy. All patients had MV insuffi-
ciency grade III-IV. Etiology of MV insufficiency was dif-
ferent (myxomatous, rheumatic, ischemic and as an
result of endocarditis). In case of MV insufficiency grade
II due to ischemic etiology, intraoperative dynamic test-
ings were made (volume overload in combination with
pressure-afterload test). In case of MV insufficiency pro-
gresion we performed MV surgery.
Statistical analysis
Data are presented as mean ± standard deviation. The
c2-test and Fisher Exact test were used to compare vari-
ables. The nonparametric Mann-Whitney test was used
to calculate the difference between the two groups. Anal-
ysis was performed with MedCalc Software (MedCalc
Inc., Mariakerke, Belgium). A value of p<0.05 was re-
quired for significance.
Results
Eighty patients were divided in two groups; 40 pa-
tients undergoing MV repair and 40 patients undergoing
MV replacement. Due to other cardiac pathology, ex-
tended surgical procedures were made. Basic demogra-
phic and preoperative values were not significantly dif-
ferent between groups. Intraoperative ischemic time was
significantly longer in MV repair group. Number and
type of concomitant procedures were not significantly
different between groups (Table 2). Postoperatively only
difference was in prolonged ventilatory support in MV
repair group (Table 3).
Discussion
In this study we have evaluated postoperative hospi-
tal mortality and morbidity after mitral valve surgery,
comparing MV repair versus MV replacement in popula-
tion older than 70 years. MV disease is an increasing
medical problem mainly due to an ageing population and
treatment of other cardiac diseases8–18. MV replacement
is simple and relatively quick operation and has achieved
predictable and good long-term results. Reconstruction
of MV, developed and popularized by Carpentier, became
a standard in degenerative mitral regurgitation or dilata-
tion of mitral annulus11–14. Although MV repair is time
consuming (106,75 min of ischemic time in repair group
versus 86,46 min in replacement group) especially in el-
derly patients, the overall results are not different. In
some cases the implantation of artificial chordae had to
be added to MV repair to eliminate incompetence, which
was also, the reason for prolonged ischemic time in re-
pair group. We think that prolonged ventilatory support
time can be associated with prolonged ischemic time.
Both did not influence postoperative morbidity and mor-
tality.












previous IM 4 3
hypercholesterolemia 7 9
hypertension 7 12
ejection fraction 40% 45%
Euro-score 16.94 % 15.76%








mean bypass time 130 min 120.06 min
mean ischemic time 106.75 min 86.46 min
concomitant procedure
CABG 7 10
TV anuloplasty 15 12
AV replacement 15 10
Aortic surgery 2 1























ICU stay/days 5.2 4.2
in-hospital stay/days 15 13.5
in-hospital death 2 1
After evaluating mitral regurgitation grade>II, using
transoesophageal echocardiography in operating room,
in 3 cases MV replacement was preformed following in-
adequate repair.
We had 3 in hospital deaths. In MV repair group one
patient died from perioperative myocardial infarction,
and other from multiorgan failure. In replacement group
one patient died from rupture of ventricle in emphati-
cally calcified posterior part of mitral valve annulus.
In summary, there was no difference in any of two
techniques regarding hospital mortality and morbidity
postoperatively. According to our results we think that
MV repair is safe technique when feasible, even in el-
derly patients. Experienced surgeon should perform MV
repair to minimize repair failure and prolong bypass
time.
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JE LI POPRAVAK MITRALNOG ZALISTKA SIGURAN ZAHVAT U STARIJIH OSOBA?
S A @ E T A K
Cilj ove randomizirane prospektivne studije bio je procijeniti poslijeoperacijski mortalitet i morbiditet nakon po-
pravka mitralnog zalistka, uspore|uju}i dvije kirur{ke tehnike lije~enja mitralne insuficijencije u starijih bolesnika.
Uspore|ivao se popravak i zamjena mitralnog zalistka u bolesnika starijih od 70 godina. U razdoblju od 1. sije~nja 2007.
do 30. kolovoza 2009., 80 pacijenata sa bolesti mitralnog zalistka, izoliranom ili udru`enom s ostalim komorbiditetima,
predvi|eno je za popravak ili za zamjenu mitralnog zalistka u na{oj ustanovi. Bolesnici su randomizirani u dvije sku-
pine (popravak ili zamjena) pomo}u omotnica s metodom slu~ajnih brojeva. Rezultati ne pokazuju razliku u poslije-
operacijskom bolni~kom mortalitetu i morbiditetu. U skupini bolesnika podvrgnutih zamjeni mitralnog zalistka, imali
smo jednu zna~ajnu komplikaciju u obliku rupture lijevog ventrikla uz nalaz zna~ajno kalcificiranog stra`njeg dijela
prstena mitralnog zalistka. U kona~nici, nismo na{li zna~ajnih razlika koje bi davale prednost jednoj od navedenih
tehnika, s obzirom na bolni~ki mortaltet i morbiditet.
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